Clinical Trial

CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).

Study acronym: CHOICE2
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Multi-center, randomized, parallel-group, superiority study to compare the efficacy of adjunct intra-arterial rt-PA versus not adjunct intra-arterial rt-PA in the improvement of the efficacy of mechanical thrombectomy in patients with large vessel occlusion acute ischemic stroke.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-03-21; most recent amendment 2025-09-08.
Status change: Recruiting → Active, Not Recruiting 2025-09-08
Status change: Not Yet Recruiting → Recruiting 2025-03-07
Trial Details
NCT Number NCT05797792
Lead Sponsor Hospital Clinic of Barcelona
Conditions Stroke, Acute Ischemic, Stroke, Acute
Enrollment 440 participants
Start Date 2023-11-18
Primary Completion 2025-08-26 (estimated)
Study Completion 2025-11-14 (estimated)
Updated on ClinicalTrials.gov 2025-09-15